v3.25.4
FAIR VALUE MEASUREMENTS (Tables)
12 Months Ended
Dec. 31, 2025
Fair Value Disclosures [Abstract]  
Schedule of components and classification of financial assets and liabilities measured at fair value
The following fair value hierarchy table presents the components and classification of the Company's financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2025 and 2024:
 December 31, 2025December 31, 2024
 (in millions)
Carrying
Value
Level 1Level 2Level 3
Carrying
Value
Level 1Level 2Level 3
Assets:        
Cash equivalents$62 $50 $12 $— $60 $50 $10 $— 
Foreign currency exchange contracts$— $— $— $— $$— $$— 
Liabilities:
Acquisition-related contingent consideration$96 $— $— $96 $123 $— $— $123 
Foreign currency exchange contracts$$— $$— $$— $$— 
Cross-currency swaps$153 $— $153 $— $34 $— $34 $— 
Schedule of assets and liabilities associated with derivatives, included in the Consolidated Balance Sheets
The assets and liabilities associated with the Company's cross-currency swaps as included in the Consolidated Balance Sheets are as follows:
(in millions)December 31, 2025December 31, 2024
Other non-current liabilities$158 $40 
Prepaid expenses and other current assets$$
Net fair value$153 $34 
The assets and liabilities associated with the Company’s foreign exchange contracts as included in the Consolidated Balance Sheets December 31, 2025 and December 31, 2024 are as follows:
(in millions)December 31,
2025
December 31,
2024
Accrued and other current liabilities$(2)$(3)
Prepaid expenses and other current assets$— $
Net fair value$(2)$
Schedule of effect of hedging instruments on financial statements
The following table presents the effect of hedging instruments on the Consolidated Statements of Comprehensive Loss and the Consolidated Statements of Operations as of December 31, 2025 and 2024:
(in millions)20252024
(Loss) gain recognized in Other comprehensive income (loss)$(118)$50 
Gain excluded from assessment of hedge effectiveness$10 $13 
Location of gain of excluded componentInterest ExpenseInterest Expense
Schedule of foreign exchange contracts on the Consolidated Statements of Operations and Consolidated Statements of Cash Flows
The following table presents the effect of the Company’s foreign exchange contracts on the Consolidated Statements of Operations and the Consolidated Statements of Cash Flows for 2025 and 2024:
(in millions)20252024
(Loss) gain related to changes in fair value$(6)$
Loss related to settlements$(10)$(2)
Schedule of reconciliation of contingent consideration obligations measured on a recurring basis using significant unobservable inputs (Level 3)
The following table presents a reconciliation of contingent consideration obligations measured on a recurring basis using significant unobservable inputs (Level 3) for the years 2025 and 2024:
(in millions)20252024
Balance, beginning of period$123 $44 
Adjustments to Acquisition-related contingent consideration:
Accretion for the time value of money$13 $
Fair value adjustments due to changes in estimates of future payments(40)(13)
Acquisition-related contingent consideration adjustments(27)(9)
Additions (Note 4)— 89 
Payments/Settlements— (1)
Balance, end of period96 123 
Current portion included in Accrued and other current liabilities15 
Non-current portion$92 $108